Tagworks Pharmaceuticals BV (Tagworks), the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures. They join existing investors including Meneldor and Oost NL. In conjunction with the…